Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin

As availability of precision therapies expands, a well-validated circulating cell-free DNA (cfDNA)-based comprehensive genomic profiling assay has the potential to provide considerable value as a complement to tissue-based testing to ensure potentially life-extending therapies are administered to pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodhouse, Ryan, Li, Meijuan, Hughes, Jason, Delfosse, David, Skoletsky, Joel, Ma, Pei, Meng, Wei, Dewal, Ninad, Milbury, Coren, Clark, Travis, Donahue, Amy, Stover, Dan, Kennedy, Mark, Dacpano-Komansky, Jennifer, Burns, Christine, Vietz, Christine, Alexander, Brian, Hegde, Priti, Dennis, Lucas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518588/
https://www.ncbi.nlm.nih.gov/pubmed/32976510
http://dx.doi.org/10.1371/journal.pone.0237802

Ejemplares similares

Ejemplares similares